Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medicus PharmaMDCX +1.53%12 Cash Ratio is 1.40 as of Jun. 2026, which is 24% above its 10-year median of 1.13. GuruFocus rates MDCX with a GF Score™ of 12/100. The stock has 2 warning signs investors should review. Among 935 Drug Manufacturers companies, Medicus Pharma ranks better than 70.05% on this metric.
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Medicus Pharma Cash Ratio Related Terms
Medicus Pharma Cash Ratio Historical Data
* Premium members only.
The historical data trend for Medicus Pharma's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Medicus Pharma's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicus Pharma Cash Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Medicus Pharma's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Medicus Pharma's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicus Pharma (MDCX) has a Cash Ratio of 1.40 as of Jun. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Medicus Pharma and its competitors. This is 24% above median its historical median of 1.13. Over the past decade, Medicus Pharma's Cash Ratio has ranged from 0.01 to 3.19. According to the industry distribution chart, Medicus Pharma ranks #280 out of 935 companies in the Drug Manufacturers industry, placing it in the top 29.9%.
Is Medicus Pharma's Cash Ratio too high?
Medicus Pharma's current Cash Ratio of 1.40 is 24% above median its 10-year median of 1.13. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 3.19. The Drug Manufacturers industry median Cash Ratio is 0.62. Medicus Pharma's value of 1.40 is 125.8% above this industry median. Based on the distribution chart, Medicus Pharma ranks #280 out of 935 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Medicus Pharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Medicus Pharma's Cash Ratio compare to NSRX and MIRA?
According to the Drug Manufacturers industry distribution chart, Medicus Pharma ranks #280 out of 935 companies for Cash Ratio. This puts Medicus Pharma in the upper half of its industry. The industry median Cash Ratio is 0.62. Medicus Pharma's value of 1.40 is 125.8% above this benchmark. Historically, Medicus Pharma's own Cash Ratio has ranged from 0.01 to 3.19 over the past decade. While the company's 10-year median is 1.13 vs. the industry median of 0.62, Medicus Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Drug Manufacturers company?
The median Cash Ratio among Drug Manufacturers companies is 0.62, based on 935 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medicus Pharma's current Cash Ratio of 1.40 is 125.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Medicus Pharma and its competitors. For the Drug Manufacturers industry, the median Cash Ratio is 0.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicus Pharma's current Cash Ratio is 1.40, which is 24% above median its own 10-year median of 1.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicus Pharma stock overvalued right now?
Medicus Pharma (MDCX) has a current Cash Ratio of 1.40. The current Cash Ratio is 1.40, which is 24% above median its 10-year median of 1.13 and 125.8% above the Drug Manufacturers industry median of 0.62. Medicus Pharma's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Medicus Pharma (MDCX), the current Cash Ratio is 1.40 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
12GF Score
Get the complete analysis for MDCX
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDCX has been successfully added to your 
